ZYBT - יחס שווי חברה לקצב צמיחת הרווח jlzybio.com
Zhengye Biotechnology (ZYBT) efficiency is based on partnerships with agricultural holdings to develop vaccines. The current PEG value in the indicator's chronology on the GURU.Markets chart demonstrates valuation dynamics, where 0.00 is the current level of the metric. Fundamentals are supported by the low cyclicality of veterinary services and cost optimization through outsourcing the production of basic drugs to third-party factories.
פילוחי מדדים ואנליטיקה של חברת Zhengye Biotechnology (ZYBT)
The PEG ratio correlates the P/E ratio with revenue growth rates, enabling the identification of undervalued assets with high growth potential, where values below one signal fundamental attractiveness. By analyzing the fair value PEG dynamics for Zhengye Biotechnology (ZYBT), an investor can assess the effectiveness of expansion within the veterinary biologicals sector and the impact of production modernization on the company's future capitalization.
